NanoVibronix, Inc. announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (RCT) study of UroShield.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7585 USD | +1.13% | -5.19% | -34.04% |
1st Jan change | Capi. | |
---|---|---|
-34.04% | 2.11M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- NAOV Stock
- News NanoVibronix, Inc.
- NanoVibronix, Inc. Signs Research Agreement for Clinical Study of UroShield with University of Michigan